TI
RPRX icon

Tidal Investments’s Royalty Pharma RPRX Stock Holding History

Tidal Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.63M Buy
118,323
+88,642
+299% +$4.61M 0.01% 838
2026
Q1 		$1.42M Sell
29,681
-12,652
-30% -$554K ﹤0.01% 1279
2025
Q4 		$1.64M Buy
42,333
+11,243
+36% +$429K ﹤0.01% 1033
2025
Q3 		$1.1M Sell
31,090
-27
-0.1% -$977 ﹤0.01% 1169
2025
Q2 		$1.12M Sell
31,117
-344
-1% -$11.4K 0.01% 985
2025
Q1 		$979K Sell
31,461
-6,914
-18% -$219K 0.01% 985
2024
Q4 		$979K Sell
38,375
-9,371
-20% -$248K 0.01% 1010
2024
Q3 		$1.35M Sell
47,746
-625
-1% -$17.3K 0.01% 848
2024
Q2 		$1.28M Sell
48,371
-41,778
-46% -$1.16M 0.02% 769
2024
Q1 		$2.74M Buy
90,149
+19,834
+28% +$585K 0.05% 409
2023
Q4 		$1.98M Buy
70,315
+13,213
+23% +$363K 0.05% 364
2023
Q3 		$1.55M Buy
57,102
+504
+0.9% +$15K 0.05% 389
2023
Q2 		$1.74M Buy
56,598
+614
+1% +$20.8K 0.05% 362
2023
Q1 		$2.02M Buy
55,984
+4,468
+9% +$166K 0.07% 286
2022
Q4 		$2.04M Buy
51,516
+8,743
+20% +$365K 0.08% 275
2022
Q3 		$1.72M Buy
42,773
+1,603
+4% +$68.5K 0.07% 250
2022
Q2 		$1.73M Buy
41,170
+6,433
+19% +$264K 0.06% 255
2022
Q1 		$1.35M Buy
34,737
+13,689
+65% +$538K 0.04% 340
2021
Q4 		$839K Sell
21,048
-3,620
-15% -$141K 0.03% 457
2021
Q3 		$901K Buy
24,668
+18,708
+314% +$727K 0.03% 359
2021
Q2 		$244K Buy
+5,960
New +$254K 0.01% 639

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidal Investments's RPRX Position: Q2 2026 in Review

Tidal Investments increased its Royalty Pharma (RPRX) stake by 299% in Q2 2026, buying an estimated $4.61M and bringing the position to 118,323 shares worth $6.63M. The position accounts for 0.01% of the portfolio, ranked #838.

Tidal Investments first reported a position in RPRX in Q2 2021 and has held it in 21 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Tidal Investments held 118,323 shares of Royalty Pharma worth $6.63M as of Q2 2026.
  • Tidal Investments bought 88,642 Royalty Pharma shares in Q2 2026, an estimated $4.61M.
  • Royalty Pharma made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #838 holding.
  • Tidal Investments first reported a position in Royalty Pharma in Q2 2021 and has held it in 21 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.